Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis

British Journal of Dermatology

Volumn 152, Issue 6, 2005, Pages 1211-1218

  Boyman, O ^a,b   Conrad, C ^a   Dudli, C ^a   Kielhorn, E ^c   Nickoloff, B J ^c   Nestle, Frank O ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antigen presenting cell; CD91; Heat shock protein; Innate immunity; Pattern recognition receptor; Psoriasis

Indexed keywords

ANTIBODY CONJUGATE; ANTIGEN; COMMON HEAT SHOCK PROTEIN RECEPTOR; FLUOROCHROME; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LYMPHOCYTE SURFACE MARKER; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; EXPERIMENTAL MODEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KERATINOCYTE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; RELAPSE; SIGNAL TRANSDUCTION; SKIN BIOPSY; T LYMPHOCYTE ACTIVATION; XENOGRAFT;

ANIMALS; ANTIGENS, CD; BIOPSY; CASE-CONTROL STUDIES; CHRONIC DISEASE; DENDRITIC CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; KERATINOCYTES; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MODELS, ANIMAL; PSORIASIS; RECURRENCE; SKIN; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 21644439478     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06701.x     Document Type: Article

References (33)

1. Griffiths CE, Voorhees JJ. Psoriasis, T cells and autoimmunity. J R Soc Med 1996; 89:315-19.
2. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002; 46:1-23.
3. Barker JN. The pathophysiology of psoriasis. Lancet 1991; 338:227-30.
4. Chang JC, Smith LR, Froning KJ et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sci USA 1994; 91:9282-6.
5. Gottlieb SL, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995; 1:442-7.
6. Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98:1878-87.
7. Boyman O, Hefti HP, Conrad C et al. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J Exp Med 2004; 199:731-6.
8. Nickoloff BJ. Skin innate immune system in psoriasis: friend or foe? J Clin Invest 1999; 104:1161-4.
9. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16:3-9.
10. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-71.
11. Basu S, Binder RJ, Ramalingam T et al. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001; 14:303-13.
12. Reis e Sousa C. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 2004; 16:27-34.
13. Fraki JE, Briggaman RA, Lazarus GS. Transplantation of psoriatic skin onto nude mice. J Invest Dermatol 1983; 80 (Suppl.): S31-5.
14. Curry JL, Qin JZ, Bonish B et al. Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med 2003; 127:178-86.
15. Baker BS, Ovigne JM, Powles AV et al. Normal keratinocytes express toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 2003; 148:670-9.
16. Gardai SJ, Xiao YQ, Dickinson M et al. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003; 115:13-23.
17. Stebbing J, Gazzard B, Kim L et al. The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected 'true' long-term nonprogressors. Blood 2003; 101:4000-4.
18. Hart JP, Gunn MD, Pizzo SV. A CD91-positive subset of CD11c+ blood dendritic cells: characterization of the APC that functions to enhance adaptive immune responses against CD91-targeted antigens. J Immunol 2004; 172:70-8.
19. Stebbing J, Gazzard B, Portsmouth S et al. Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. Blood 2003; 102:1806-14.
20. Porcelli SA, Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999; 17:297-329.
21. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996; 93:2588-92.
22. Boehncke WH, Dahlke A, Zollner TM et al. Differential expression of heat shock protein 70 (HSP70) and heat shock cognate protein 70 (HSC70) in human epidermis. Arch Dermotol Res 1994; 287:68-71.
23. Milarski KL, Morimoto RI. Expression of human HSP70 during the synthetic phase of the cell cycle. Proc Natl Acad Sci USA 1986; 83:9517-21.
24. Nestle FO, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest 1994; 94:202-9.
25. Lew W, Bowcock AM, Krueger JG. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and 'type 1' inflammatory gene expression. Trends Immunol 2004; 25:295-305.
26. Gudjonsson JE, Johnston A, Sigmundsdottir H et al. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004; 135:1-8.
27. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13:114-19.
28. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002; 20:395-425.
29. Millar DG, Garza KM, Odermatt B et al. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med 2003; 9:1469-76.
30. Basu S, Binder RJ, Suto R et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000; 12:1539-46.
31. Singh-Jasuja H, Scherer HU, Hilf N et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 2000; 30:2211-15.
32. Mease PJ, Goffe BS, Metz J et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000; 356:385-90.
33. Chaudhari U, Romano P, Mulcahy LD et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001; 357:1842-7.